Jane Street’s 1Life Healthcare ONEM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-31,100
Closed -$520K 10492
2022
Q4
$520K Sell
31,100
-7,200
-19% -$122K ﹤0.01% 6062
2022
Q3
$657K Buy
38,300
+17,700
+86% +$278K ﹤0.01% 6181
2022
Q2
$162K Sell
20,600
-15,500
-43% -$133K ﹤0.01% 8355
2022
Q1
$400K Sell
36,100
-111,100
-75% -$1.24M ﹤0.01% 7892
2021
Q4
$2.59M Buy
147,200
+26,300
+22% +$510K ﹤0.01% 3971
2021
Q3
$2.45M Buy
120,900
+109,300
+942% +$2.81M ﹤0.01% 4063
2021
Q2
$383K Sell
11,600
-15,800
-58% -$596K ﹤0.01% 7744
2021
Q1
$1.07M Buy
27,400
+20,200
+281% +$948K ﹤0.01% 5326
2020
Q4
$314K Sell
7,200
-22,500
-76% -$769K ﹤0.01% 6337
2020
Q3
$842K Buy
29,700
+3,800
+15% +$120K ﹤0.01% 4375
2020
Q2
$941K Buy
+25,900
New +$729K ﹤0.01% 4151

Jane Street's ONEM Position: Q1 2023 in Review

Jane Street sold out of 1Life Healthcare (ONEM) in Q1 2023, closing a stake of 173,080 shares — an estimated $2.89M sold.

Jane Street first reported a position in ONEM in Q2 2020 and held it in 11 quarters. The position peaked at $4.02M in Q2 2020. 0 funds tracked by Wall St. Rank hold ONEM as of Q1 2023.

  • Jane Street reported no remaining 1Life Healthcare position as of Q1 2023 after selling out during the quarter.
  • Jane Street sold 173,080 1Life Healthcare shares in Q1 2023, an estimated $2.89M.
  • Jane Street first reported a position in 1Life Healthcare in Q2 2020 and held it in 11 quarters.
  • Jane Street's 1Life Healthcare position peaked at $4.02M in Q2 2020.
  • 0 funds tracked by Wall St. Rank held 1Life Healthcare as of Q1 2023.

Based on Jane Street's 13F filing for Q1 2023, filed 16 May 2023.